Financial Advocates Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,025	Closed	-$490K	–	747
2021 Q2	$490K	Buy	+3,025	New	+$490K	0.03%	472
2021 Q1	–	Sell	-1,377	Closed	-$211K	–	736
2020 Q4	$211K	Buy	+1,377	New	+$211K	0.01%	665